2022
DOI: 10.1148/rg.220036
|View full text |Cite
|
Sign up to set email alerts
|

Musculoskeletal Manifestations of COVID-19: Currently Described Clinical Symptoms and Multimodality Imaging Findings

Abstract: COVID-19, the clinical syndrome produced by infection with SARS-CoV-2, can result in multisystem organ dysfunction, including respiratory failure and hypercoagulability, which can lead to critical illness and death. Musculoskeletal (MSK) manifestations of COVID-19 are common but have been relatively underreported, possibly because of the severity of manifestations in other organ systems. Additionally, patients who have undergone sedation and who are critically ill are often unable to alert clinicians of their … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0
2

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 77 publications
0
8
0
2
Order By: Relevance
“…MR imaging was used to diagnose various COVID-19–related MSK findings, most commonly for patients with prolonged hospitalizations [ 54 , 55 ]. MSK manifestations of COVID-19 may persist or occur months after the initial infection, known as post-COVID syndrome [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…MR imaging was used to diagnose various COVID-19–related MSK findings, most commonly for patients with prolonged hospitalizations [ 54 , 55 ]. MSK manifestations of COVID-19 may persist or occur months after the initial infection, known as post-COVID syndrome [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…A previous study reported that during the pandemic, the number of radiologists in the office decreased dramatically as more people chose to work from home [ 31 ]. Possibly because of the greater severity of other organ system manifestations of COVID-19, the musculoskeletal (MSK) manifestations of this virus have not been completely reported [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, the incidence of thrombotic events possibly associated with the clinical profile of COVID-19 patients may also contribute with poor vascularization of peripheral vessels in the muscles ( 4 ) and might generate biochemical repercussions in the musculoskeletal system. The pathogenetic mechanisms can also involve increased production of proinflammatory cytokines, immune cell hyperactivation, direct viral entry of neurological and musculoskeletal system cells, and psychological stress ( 18 25 ). The cognitive and behavioral aspects may be also associated with the occurrence of musculoskeletal pain in these patients ( 18 22 ).…”
Section: Introductionmentioning
confidence: 99%
“…The cognitive and behavioral aspects may be also associated with the occurrence of musculoskeletal pain in these patients ( 18 22 ). Considering specifically joint pain, some findings show a prevalence that may vary between 2.5% and 23% of patients ( 21 25 ). Myalgias and generalized weakness have also been reported in studies with a prevalence between 25% and 50% of symptomatic COVID-19 patients ( 23 ).…”
Section: Introductionmentioning
confidence: 99%